Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis

Clinical Biochemistry

Volumn 40, Issue 11, 2007, Pages 776-780

  Baskol, Gulden ^a   Baskol, Mevlut ^a   Kocer, Derya ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Nitric oxide; Non alcoholic steatohepatitis; Paraoxonase; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOL; XANTHINE OXIDASE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; ALCOHOLS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; FEMALE; GLUTATHIONE PEROXIDASE; HEPATITIS; HUMANS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 34250759386     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.02.006     Document Type: Article

References (40)

1. Sheth S.G., Gordon F.D., and Chopra S. Non alcoholic steatohepatitis. Ann. Intern. Med. 126 (1997) 137-145
2. Ludwig J., McGill D.B., and Lindor K.D. Non alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 12 (1997) 398-403
3. Robertson G., Leclercq I., and Farrell G.C. Nonalcoholic steatosis and steatohepatitis II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol.: Gastrointest. Liver Physiol. 281 (2001) 1135-1139
4. Laurent A., Nicco C., Tran Van Nhieu J., et al. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39 (2004) 1277-1285
5. Gulec M., Akin H., Yuce H., et al. Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study. Clin. Biochem. 36 (2003) 193-196
6. Karabulut A.B., Kafkasli{dotless} A., Burak F., and Gozukara E. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem. Funct. 23 (2005) 279-283
7. Many A., Hubel C.A., Fisher S.J., Roberts J.M., and Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol. 56 (2000) 321-331
8. Michiels C., Rase M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol. Med. 17 (1994) 235-248
9. Cadenas E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 58 (1989) 79-110
10. Hu M.L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 233 (1994) 381-385
11. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol. 271 (1996) 3424-3437
12. Jourd'heuil F.L., Kutchukian P.S., Musah R.A., Wink D.A., and Grisham M.B. Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J. Biol. Chem. 276 (2001) 28799-28805
13. Jepsen P., Vilstrup H., Mellemkjaer L., et al. Prognosis of patients with a diagnosis of fatty liver: a registry-based cohort study. Hepatogastroenterology 50 (2003) 2101-2104
14. Esterbauer H., Wag G., and Puhl H. Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49 (1993) 566-576
15. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J. Clin. Invest. 101 (1998) 1581-1590
16. Chang C.Y., Argo C.K., Al-Osaimi A.M., and Caldwell S.H. Therapy of NAFLD: antioxidants and cytoprotective agents. J. Clin. Gastroenterol. 40 (2006) 51-60
17. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94 (1999) 2467-2474
18. Prajde N., and Weber G. Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett. 59 (1975) 245-249
19. Sun Y., Oberley L.W., and Li Y.A. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
20. Paglia D.E., and Valentina W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
21. Hu M.L., Locie S., Cross C.E., Motchnik P., and Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 121 (1993) 257-262
22. Bories P.N., and Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin. Chem. 41 (1995) 904-907
23. Eckerson E.W., Romson J., Wyte C., and La Du B.N. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am. J. Hum. Genet. 35 (1983) 214-227
24. Koruk M., Taysi S., Savas M.C., Yilmaz O., Akcay F., and Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann. Clin. Lab. Sci. 34 1 (2004) 57-62
25. Villanova N., Moscatiello S., Ramilli S., et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42 (2005) 473-480
26. Raij L. Nitric oxide in the pathogenesis of cardiac disease. J. Clin. Hypertens. (Greenwich) 8 (2006) 30-39
27. Park K.S., Jang B.K., Kwon K.M., Chung W.J., Cho K.B., and Hwang J.S. Antioxidant status in nonalcoholic steatohepatitis. Korean J. Hepatol. 11 (2005) 135-143
28. Nobili V., Pastore A., Gaeta L.M., Tozzi G., Comparcola D., and Sartorelli M.L. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin. Chim. Acta 355 (2005) 105-111
29. Granger D.N., Hollwarth M.E., and Parks D.A. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol. Scand. 548 (1986) 47-63
30. Poniachik J., Csendes A., Diaz J.C., et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 33 (2006) 252-257
31. Houston M., Estevez A., Chumley P., et al. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J. Biol. Chem. 274 (1999) 4985-4994
32. Ayub A., Mackness M.I., Arrol S., Mackness B., Patel J., and Durrington P.N. Serum paraoxonase after myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 330-335
33. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., and Ishola M. Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus. Atherosclerosis 86 (1991) 193-199
34. Baskol M., Baskol G., Deniz K., Ozbakir O., and Yucesoy M. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. Turk. J. Gastroenterol. 16 (2005) 119-123
35. Aviram M., Rosenblat M., Billecke S., et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol. Med. 26 (1999) 892-904
36. Baskol G., Demir H., Baskol M., et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin. Biochem. 38 (2005) 951-955
37. Baskol G., Karakucuk S., Oner A.O., et al. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age related macular degeneration. Ophthalmologica 220 (2006) 12-16
38. Baskol G., Baskol M., Yurci A., Ozbaki{dotless}r O., and Yucesoy M. Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem. Funct. 24 (2006) 283-286
39. Karakucuk S., Baskol G., Oner A., Mirza E., and Ustdal M. Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br. J. Ophthalmol. 88 (2004) 1256-1258
40. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605